News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,285 Results
Type
Article (44028)
Company Profile (312)
Press Release (683945)
Multimedia
Podcasts (74)
Webinars (13)
Section
Business (211885)
Career Advice (2097)
Deals (36398)
Drug Delivery (100)
Drug Development (82304)
Employer Resources (176)
FDA (16741)
Job Trends (15325)
News (356186)
Policy (33420)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (52478)
ALS (94)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (140)
Approvals (16738)
Artificial intelligence (289)
Autoimmune disease (23)
Automation (16)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (221)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (292)
Cancer (2330)
Cardiovascular disease (182)
Career advice (1757)
Career pathing (31)
CAR-T (161)
Cell therapy (448)
Cervical cancer (20)
Clinical research (66854)
Collaboration (886)
Company closure (1)
Compensation (563)
Complete response letters (19)
COVID-19 (2677)
CRISPR (47)
C-suite (260)
Cystic fibrosis (105)
Data (2316)
Decentralized trials (2)
Denatured (30)
Depression (45)
Diabetes (277)
Diagnostics (6646)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (103)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (88493)
Editorial (37)
Employer branding (22)
Employer resources (151)
Events (117318)
Executive appointments (760)
FDA (18108)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (794)
Gene editing (119)
Generative AI (26)
Gene therapy (325)
GLP-1 (734)
Government (4524)
Grass and pollen (5)
Guidances (130)
Healthcare (19540)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (30)
Infectious disease (2825)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (101)
Interviews (324)
IPO (16860)
IRA (41)
Job creations (3821)
Job search strategy (1494)
Kidney cancer (10)
Labor market (40)
Layoffs (484)
Leadership (18)
Legal (8129)
Liver cancer (78)
Lung cancer (326)
Lymphoma (158)
Machine learning (8)
Management (62)
Manufacturing (328)
MASH (72)
Medical device (14115)
Medtech (14120)
Mergers & acquisitions (20112)
Metabolic disorders (709)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1958)
NextGen: Class of 2025 (6844)
Non-profit (4618)
Now hiring (40)
Obesity (373)
Opinion (217)
Ovarian cancer (77)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (248)
Patient recruitment (116)
Peanut (49)
People (59573)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (20981)
Phase II (29424)
Phase III (21827)
Pipeline (1314)
Policy (147)
Postmarket research (2582)
Preclinical (9008)
Press Release (71)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (389)
Real estate (6235)
Recruiting (65)
Regulatory (22898)
Reports (46)
Research institute (2459)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (137)
Series B (89)
Service/supplier (15)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3843)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (46)
The Weekly (42)
Vaccines (728)
Venture capitalists (42)
Weight loss (242)
Women's health (36)
Worklife (16)
Date
Today (197)
Last 7 days (930)
Last 30 days (3032)
Last 365 days (33472)
2025 (11700)
2024 (36219)
2023 (41138)
2022 (52398)
2021 (56995)
2020 (55613)
2019 (48407)
2018 (36441)
2017 (33542)
2016 (33142)
2015 (39360)
2014 (32942)
2013 (27986)
2012 (30243)
2011 (30848)
2010 (28810)
Location
Africa (759)
Alabama (54)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (40550)
Australia (6744)
California (6430)
Canada (2058)
China (544)
Colorado (277)
Connecticut (287)
Delaware (162)
Europe (88782)
Florida (941)
Georgia (219)
Idaho (60)
Illinois (568)
India (26)
Indiana (324)
Iowa (11)
Japan (171)
Kansas (108)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (922)
Massachusetts (4833)
Michigan (244)
Minnesota (407)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (67)
New Hampshire (69)
New Jersey (1799)
New Mexico (28)
New York (1812)
North Carolina (1030)
North Dakota (9)
Northern California (2804)
Ohio (213)
Oklahoma (15)
Oregon (37)
Pennsylvania (1427)
Puerto Rico (13)
Rhode Island (34)
South America (1155)
South Carolina (25)
South Dakota (1)
Southern California (2417)
Tennessee (106)
Texas (950)
United States (24254)
Utah (194)
Virginia (154)
Washington D.C. (65)
Washington State (576)
West Virginia (3)
Wisconsin (59)
728,285 Results for "vitreoretinal technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Vitreoretinal Surgeon and Key Thought Leader Roger Goldberg, M.D., Joins Kiora Pharmaceuticals’ Scientific Advisory Board
Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Roger A. Goldberg, MD, MBA, a vitreoretinal surgeon at Bay Area Retina Associates (BARA) to its Scientific Advisory Board. As an advisor, Dr. Goldberg will contribute scientific insights and valued clinical perspectives to aid Kiora’s development of new therapeutics to address retinal diseases with high unmet needs.
June 25, 2024
·
5 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Policy
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that UNITY® Vitreoretinal Cataract System and UNITY® Cataract System have received U.S. Food and Drug Administration 510 clearance.
June 24, 2024
·
6 min read
1 of 72,829
Next
